Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

A Cellular Therapy with Haploidentical Peripheral Hematopoietic STEM CELL Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease

Simona Sammassimo, Daniele Avenoso, Federica Gigli, Daniele Laszlo, MD, Francesco Bertolini, MD PhD, Giammarco Russo, Corrado Tarella, MD Prof, Rocco Pastano

Blood (2018) 132 (Supplement 1): 2189.

https://doi.org/10.1182/blood-2018-99-119752

Published: 2018

Journal Articles

Rituximab Maintenance Treatment for a Maximum of 5 Years in Follicular Lymphoma: Final Results of the Randomized Phase III Trial SAKK 35/03

Christian Taverna, MD, Giovanni Martinelli, MD, Felicitas Hitz, MD, Walter Mingrone, MD, Thomas Pabst, MD PhD, Lidija Cevreska, MD PhD, Auro del Giglio, MD, Anna Vanazzi, MD, Daniele Laszlo, MD, Johann Raats, Daniel Rauch, Daniel Vorobiof, Andreas Lohri, MD, Emanuele Zucca, Celine Rueegsegger, Stephanie - Rondeau, Corinne Rusterholz, Michele Ghielmini

Blood (2018) 132 (Supplement 1): 1601.

https://doi.org/10.1182/blood-2018-99-116864

Published: 2018

Journal Articles

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

Andrei Shustov, MD, Maria Elena Cabrera, Monica Bellei, MSc, PhD, Young Hyeh Ko, MD, Martina Manni, PhD, Steven M. Horwitz, MD, Carmino Antonio De Souza, MD PhD, John A. Radford, MD, Sabela Bobillo Varela, Maria Virginia Prates, MD, Andrés J M Ferreri, MD, Carlos Chiattone, MD, Michele Spina, MD, Julie M. Vose, MDMBA, Annalisa Chiappella, MD, Daniele Laszlo, MD, Dario Marino, MDPhD, Caterina Stelitano, Massimo Federico, MD

Blood (2017) 130 (Supplement 1): 4071.

https://doi.org/10.1182/blood.V130.Suppl_1.4071.4071

Published: 2017

Journal Articles

A MALT lymphoma prognostic index

Catherine Thieblemont, Luciano Cascione, Annarita Conconi, Barbara Kiesewetter, Markus Raderer, Gianluca Gaidano, Maurizio Martelli, Daniele Laszlo, Bertrand Coiffier, Armando Lopez Guillermo, Valter Torri, Franco Cavalli, Peter W. Johnson, Emanuele Zucca

Blood (2017) 130 (12): 1409–1417.

https://doi.org/10.1182/blood-2017-03-771915

Published: 2017

Includes: Supplemental data

Journal Articles

Non-Hodgkin's Lymphomas Associated With Positive Hepatitis-C Virus Infection: A Prospective Multicentric Observational Study On Behalf Of The “Rete Ematologica Lombarda/Hematology Network Of Lombardia Region”

Sara Rattotti, Luca Arcaini, Virginia Valeria Ferretti, Andrea Rossi, Stefano Fogazzi, Antonino Greco, Luca Baldini, Monica Balzarotti, Pietro Pioltelli, Maurizio Bonfichi, Marzia Varettoni, Manuel Gotti, Lucia Farina, Andrés J.M. Ferreri, Daniele Laszlo, Enrica Morra, MD

Blood (2013) 122 (21): 3003.

https://doi.org/10.1182/blood.V122.21.3003.3003

Published: 2013

Journal Articles

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

David Wrench, MD, PhD, Hasan Rizvi, MD, Andrew Wilson, Ciaran O'Riain, MD, PhD, Andrew Clear, Janet Matthews, Daniele Laszlo, MD, T. Andrew Lister, MD, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Maria Calaminici, MD, PhD, Silvia Montoto, MD

Blood (2013) 122 (21): 4260.

https://doi.org/10.1182/blood.V122.21.4260.4260

Published: 2013

Journal Articles

Rituximab Maintenance Treatment For a Maximum Of 5 Years In Follicular Lymphoma: Results Of The Randomized Phase III Trial SAKK 35/03

Christian J. Taverna, MD, Giovanni Martinelli, Felicitas Hitz, Walter Mingrone, Thomas Pabst, MD, Lidija Cevreska, Auro del Giglio, MD, Anna Vanazzi, Daniele Laszlo, Johann Raats, Daniel Rauch, Daniel A. Vorobiof, Andreas Lohri, MD, Emanuele Zucca, MD, Christine Biaggi Rudolf, Stephanie Rondeau, Corinne Rusterholz, Michele Ghielmini, MD

Blood (2013) 122 (21): 508.

https://doi.org/10.1182/blood.V122.21.508.508

Published: 2013

Journal Articles

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia and Second Malignancy Following Yttrium-90 Ibritumomab Tiuxetan: 10-Year Single-Institution Experience of 138 Consecutive Patients

Anna Vanazzi, Chiara Grana, Daniele Laszlo, Marco Chinol, Mara Negri, Liliana Calabrese, Giovanni Paganelli, Giovanni Martinelli

Blood (2012) 120 (21): 4876.

https://doi.org/10.1182/blood.V120.21.4876.4876

Published: 2012

Journal Articles

The More Effective and the More (bio) Similar: Plerixafor and Filgrastim XM02 (tevagastrim) As First Line PBSC Mobilization Strategy in Patients with Multiple Myeloma and Lymphomas Candidate to ABMT

Daniele Laszlo, Giovanna Andreola, Aleksandra Babic, Mara Negri, Cristina Rabascio, Ambra Malerba, Monica Drera, Elezi Rufije, Giovanni Martinelli, MD

Blood (2011) 118 (21): 2994.

https://doi.org/10.1182/blood.V118.21.2994.2994

Published: 2011

Journal Articles

Rituximab Plus Chlorambucil Compared with Chlorambucil and Prednisone In Patients with Untreated Follicular Lymphoma

Simona Bassi, Simona Sammassimo, Federica Gigli, Giancarlo Pruneri, Paola Bertazzoni, Jessica Quarna, Emilia Cocorocchio, Daniele Laszlo, Mara Negri, Maria Lionetti, Anna Vanazzi, Alessandra Alietti, Alberto Agazzi, Angelo Gardellini, Giovanna Andreola, Lorenzo Preda, Rocco Pastano, Giovanni Martinelli, MD

Blood (2010) 116 (21): 3956.

https://doi.org/10.1182/blood.V116.21.3956.3956

Published: 2010

Journal Articles

90 y-Ibritumomab Tiuxetan or Purine Analogues Severely Affect Peripheral Blood Stem Cell Mobilization: An Analysis On 248 Patients.

Anna Vanazzi, MD, Alessandra Alietti, MD, Alberto Agazzi, MD, Mara Negri, Maria Teresa Lionetti, Aleksandra Babic, Davide Radice, Luca Nassi, MD, Simona Sammassimo, MD, Cristina Rabascio, Pierluigi Antoniotti, Lara Roveda, Bruno Lucchetti, Tiziana Suardi, Alessio Piredda, Liliana Calabrese, Giovanni Martinelli, MD, Daniele Laszlo, MD

Blood (2009) 114 (22): 3210.

https://doi.org/10.1182/blood.V114.22.3210.3210

Published: 2009

Journal Articles

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Simona Bassi, MD, Luca Nassi, MD, Giancarlo Pruneri, MD, Simona Sammassimo, MD, Paola Bertazzoni, MD, Federica Gigli, MD, Anna Vanazzi, MD, Emilia Cocorocchio, MD, Patrizia Mancuso, Cristina Rabascio, Maria Teresa Lionetti, Daniele Laszlo, MD, Giovanni Martinelli, MD

Blood (2009) 114 (22): 3754.

https://doi.org/10.1182/blood.V114.22.3754.3754

Published: 2009

Journal Articles

Rituximab and 2-Cda Activity in CLL/SLL Patients: An Update of Pharmacogenomic and Clinical Results

Paola Bertazzoni, Cristina Rabascio, Liliana Calabrese, Federica Gigli, Simona Bassi, MD, Luca Nassi, Simona Sammassimo, Sara Steffanoni, Davide Radice, Angelica Calleri, Emilia Cocorocchio, Daniele Laszlo, Giovanni Martinelli

Blood (2008) 112 (11): 3171.

https://doi.org/10.1182/blood.V112.11.3171.3171

Published: 2008

Journal Articles

Red Marrow Dosimetry and Stem Cell Reinfusion in High Dose 90 Y - Ibritumomab Tiuxetan.

Anna Vanazzi, Daniele Laszlo, Marta Cremonesi, Chiara Maria Grana, Stefano Papi, Alessandra Alietti, Sarah Jayne Liptrott, Liliana Calabrese, Giovanni Paganelli, Giovanni Martinelli

Blood (2008) 112 (11): 2187.

https://doi.org/10.1182/blood.V112.11.2187.2187

Published: 2008

Journal Articles

Evolving First-Line Treatments -from Chemotherapy to Immunotherapy Alone- in 143 Consecutive Follicular Lymphoma Patients Treated in the Last 14 Years at the European Institute of Oncology, Milano

Simona Bassi, MD, Federica Gigli, Cristina Rabascio, Simona Sammassimo, Patrizia Mancuso, Emilia Cocorocchio, Paola Bertazzoni, Daniele Laszlo, Giancarlo Pruneri, Liliana Calabrese, Maria Teresa Lionetti, Anna Vanazzi, MD, Alessandra Alietti, Luca Nassi, Alberto Agazzi, Rocco Pastano, Fedro Alessandro Peccatori, Giovanni Martinelli

Blood (2008) 112 (11): 5016.

https://doi.org/10.1182/blood.V112.11.5016.5016

Published: 2008

Journal Articles

Primary Female Genital Lymphoma: Prognostic and Therapeutic Considerations

Sara Steffanoni, Alberto Agazzi, Daniele Laszlo, Sarah Jane Liptrott, Mara Negri, Fedro Alessandro Peccatori, Giovanni Martinelli

Blood (2008) 112 (11): 4941.

https://doi.org/10.1182/blood.V112.11.4941.4941

Published: 2008

Journal Articles

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Simona Bassi, MD, Alessandra Alietti, MD, Chiara Corsini, DSc, Federica Gigli, MD, Paola Bertazzoni, MD, Cristina Rabascio, DSc, Patrizia Mancuso, DSc, Emilia Cocorocchio, MD, Daniele Laszlo, MD, Giancarlo Pruneri, MD, Lorenzo Preda, MD, Sarah J. Liptrott, BN, Rosaria Cascio, PH, Francesco Bertolini, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 5116.

https://doi.org/10.1182/blood.V110.11.5116.5116

Published: 2007

Journal Articles

Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.

Daniele Laszlo, MD, Cristina Rabascio, DSc, Giovanna Andreola, MD, Luca Saronni, DSc, Liliana Calabrese, DSc, Luigi Rigacci, MD, Alberto Fabbri, MD, Antonello Pinto, MD, Ferdinando Frigeri, MD, Atto Billio, MD, Graziella Pinotti, MD, Simona Sammassimo, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 1357.

https://doi.org/10.1182/blood.V110.11.1357.1357

Published: 2007

Journal Articles

Tissue Microarray (TMA) Study in DLBC Lymphomas (DLBCL): Could the Extranodal Origin Affect the Prognostic Impact of the Analysis?.

Daniele Laszlo, MD, Giancarlo Pruneri, MD, Giovanna Andreola, MD, Davide Radice, ST, Liliana Calabrese, DM, Alessandra Alietti, MD, Alberto Agazzi, MD, Anna Vanazzi, MD, Giovanni Martinelli, MD

Blood (2006) 108 (11): 2037.

https://doi.org/10.1182/blood.V108.11.2037.2037

Published: 2006

Journal Articles

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Rocco Pastano, MD, Daniele Laszlo, MD, Giovanna Andreola, MD, Federica Gigli, MD, Cristina Rabascio, Valentina Raia, Manuela Cazzanti, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5424.

https://doi.org/10.1182/blood.V106.11.5424.5424

Published: 2005

NARROW

A Cellular Therapy with Haploidentical Peripheral Hematopoietic STEM CELL Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease

Rituximab Maintenance Treatment for a Maximum of 5 Years in Follicular Lymphoma: Final Results of the Randomized Phase III Trial SAKK 35/03

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

A MALT lymphoma prognostic index

Non-Hodgkin's Lymphomas Associated With Positive Hepatitis-C Virus Infection: A Prospective Multicentric Observational Study On Behalf Of The “Rete Ematologica Lombarda/Hematology Network Of Lombardia Region”

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

Rituximab Maintenance Treatment For a Maximum Of 5 Years In Follicular Lymphoma: Results Of The Randomized Phase III Trial SAKK 35/03

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia and Second Malignancy Following Yttrium-90 Ibritumomab Tiuxetan: 10-Year Single-Institution Experience of 138 Consecutive Patients

The More Effective and the More (bio) Similar: Plerixafor and Filgrastim XM02 (tevagastrim) As First Line PBSC Mobilization Strategy in Patients with Multiple Myeloma and Lymphomas Candidate to ABMT

Rituximab Plus Chlorambucil Compared with Chlorambucil and Prednisone In Patients with Untreated Follicular Lymphoma

90 y-Ibritumomab Tiuxetan or Purine Analogues Severely Affect Peripheral Blood Stem Cell Mobilization: An Analysis On 248 Patients.

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Rituximab and 2-Cda Activity in CLL/SLL Patients: An Update of Pharmacogenomic and Clinical Results

Red Marrow Dosimetry and Stem Cell Reinfusion in High Dose 90 Y - Ibritumomab Tiuxetan.

Evolving First-Line Treatments -from Chemotherapy to Immunotherapy Alone- in 143 Consecutive Follicular Lymphoma Patients Treated in the Last 14 Years at the European Institute of Oncology, Milano

Primary Female Genital Lymphoma: Prognostic and Therapeutic Considerations

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.

Tissue Microarray (TMA) Study in DLBC Lymphomas (DLBCL): Could the Extranodal Origin Affect the Prognostic Impact of the Analysis?.

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only